Wiley Blackwell

SHERPA: Unknown

People

  1. Schoder
    Schoder
  2. Zelenetz
    Zelenetz
  3. Kumar
    Kumar
  4. Moskowitz
    Moskowitz
  5. Yahalom
    Yahalom
  6. Hamlin
    Hamlin
  7. Noy
    Noy
  8. Palomba
    Palomba
  9. Horwitz
    Horwitz
  10. Lewis
    Lewis

Groups

  1. Molecular Imaging and Therapy Service (88)
  2. Radiology, Department of (82)
  3. GSK Faculty (37)
  4. Molecular Pharmacology and Chemistry Program Faculty (34)
  5. Sloan Kettering Institute Faculty (34)
  6. Department of Medicine (32)
  7. Hematologic Malignancies, Division of (22)
  8. Sloan Kettering Institute Postdocs (21)
  9. Center for Hematologic Malignancies (20)
  10. Body Imaging Service (19)
Search Within
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (27)
  3. Review (8)
  4. Conference Paper (5)
  5. Editorial (1)
Groups
  1. Molecular Imaging and Therapy Service (88)
  2. Radiology, Department of (82)
  3. GSK Faculty (37)
  4. Molecular Pharmacology and Chemistry Program Faculty (34)
  5. Sloan Kettering Institute Faculty (34)
  6. Department of Medicine (32)

More Groups

People
  1. Steven Larson (25)
  2. Heiko Schoder (22)
  3. Ronald Finn (10)
  4. Andrew Zelenetz (8)
  5. David Straus (8)
  6. Alison Moskowitz (7)

More People

Years
  1. 2024 (7)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (7)

More Years

Publications
  1. Cancer (18)
  2. Journal of Labelled Compounds and Radiopharmaceuticals (14)
  3. Hematological Oncology (13)
  4. Journal of Magnetic Resonance Imaging (10)
  5. Journal of Surgical Oncology (5)
  6. Breast Journal (3)

More Publications

Results (88)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Late gadolinium enhancement cardiac magnetic resonance tissue characterization for cancer-associated cardiac masses: Metabolic and prognostic manifestations in relation to whole-body positron emission tomography
    Journal Article

    Chan, A. T.; Fox, J.; Perez Johnston, R.; Kim, J.; Brouwer, L. R.; Grizzard, J.; Kim, R. J.; Matasar, M.; Shia, J.; Moskowitz, C. S.; more...
    Journal of the American Heart Association (2019)

    Fulltext@MSK | Save
  • The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
    Journal Article

    Lansigan, F.; Barak, I.; Pitcher, B.; Jung, S. H.; Cheson, B. D.; Czuczman, M.; Martin, P.; Hsi, E.; Schòˆder, H.; Smith, S.; more...
    Cancer Medicine (2019)

    Fulltext@MSK | Save
  • Histone H3K36M mutation and trimethylation patterns in chondroblastoma
    Journal Article

    Lu, C.; Ramirez, D.; Hwang, S.; Jungbluth, A.; Frosina, D.; Ntiamoah, P.; Healey, J.; Zhu, G.; Chen, W.; Klein, M.; more...
    Histopathology (2019)

    Fulltext@MSK | Save
  • Functional peptide nanofibers with unique tumor targeting and enzyme-induced local retention properties
    Journal Article

    Bellat, V.; Ting, R.; Southard, T. L.; Vahdat, L.; Molina, H.; Fernandez, J.; Aras, O.; Stokol, T.; Law, B.
    Advanced Functional Materials (2018)

    Fulltext@MSK | Save
  • Hepatobiliary and pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy
    Journal Article

    Laino, M. E.; Ragucci, M.; Klimstra, D. S.; Mannelli, L.
    Journal of Gastroenterology and Hepatology (2018)

    Fulltext@MSK | Save
  • Background, current role, and potential applications of radiogenomics
    Journal Article

    Pinker, K.; Shitano, F.; Sala, E.; Do, R. K.; Young, R. J.; Wibmer, A. G.; Hricak, H.; Sutton, E. J.; Morris, E. A.
    Journal of Magnetic Resonance Imaging (2018)

    Fulltext@MSK | Save
  • A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma
    Meeting Abstract

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • The 23-gene gene expression-based assay does not predict interim PET scan results after ABVD in advanced stage classical Hodgkin lymphoma in the US Intergroup S0816 trial
    Meeting Abstract

    Scott, D. W.; Li, H.; Harvey, Y.; Chan, F.; Mottok, A.; Boyle, M.; Evens, A. M.; Schoder, H.; Straus, D. J.; Bartlett, N. L.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save